Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

NCT07059962 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2026-03-18

No results posted yet for this study

Summary

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.

Conditions

  • Kidney Disease
  • Peritoneal Dialysis (PD)
  • End Stage Kidney Disease (ESRD)

Interventions

DEVICE

Bodyport Cardiac Scale

The Bodyport Cardiac Scale captures several physiological signals, which are used to derive multiple biomarkers that reflect a user's hemodynamic and fluid status.

Sponsors & Collaborators

  • Bodyport Inc.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-09
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07059962 on ClinicalTrials.gov